03 · What You Need to Know
Sponsor disagreement can be scientifically useful or scientifically dangerous
The sponsor may actually be right
A financial interest in the outcome does not make every sponsor objection wrong. Sponsor scientists may know the intervention, technology, dataset, or regulatory context extremely well. They may identify a coding error, misunderstood variable, violated statistical assumption, incorrect factual statement, or overlooked limitation.
Researchers should therefore resist the opposite form of bias: assuming that criticism is invalid merely because it comes from an interested party.
The appropriate response is scientific. Ask what evidence supports the objection, whether the proposed correction follows the protocol and analysis plan, and whether independent scrutiny reaches the same conclusion.
Disagreement is different from interference
A sponsor can challenge your interpretation vigorously without compromising research independence. The boundary is crossed when financial or contractual power replaces scientific argument.
Scientific disagreement
The sponsor identifies evidence, methodological reasoning, or alternative analyses and asks researchers to reconsider a result or interpretation.
Inappropriate interference
The sponsor uses funding, contractual authority, data control, publication rights, employment power, or another form of leverage to require a scientifically unjustified change or prevent defensible findings from being reported.
The first can improve a paper. The second threatens the independence of the research process.
Return to what was planned before the results were known
When disagreement appears after an unfavorable result, the protocol, preregistration, and statistical analysis plan can become especially valuable.
Was the disputed outcome designated as primary beforehand? Was the analysis prespecified? Were exclusion criteria established before researchers knew which participants affected the result? Does the sponsor now want to substitute a different endpoint, subgroup, model, or time point only after seeing the findings?
A post hoc analysis is not automatically invalid. Unexpected results often generate useful new questions. But exploratory analyses should not silently replace prespecified analyses merely because they produce a more attractive answer.
This is one reason why clear arrangements concerning sponsor involvement in methods and analysis should be established before the data are examined.
Reproduce the disputed result
If the disagreement concerns the analysis, verify it rather than debating impressions.
Check data cleaning, exclusions, missing-data handling, variable coding, transformations, model assumptions, statistical code, outcome definitions, and any departures from the planned analysis. Where feasible and proportionate, independent statistical replication can be particularly useful.
If the sponsor's alternative analysis is scientifically reasonable, run it and report what it shows. If several reasonable analytical choices produce materially different conclusions, that sensitivity is itself important information and may belong in the paper.
Investigators need meaningful access to the evidence
Resolving disagreement becomes difficult if the sponsor controls the complete dataset and researchers see only selected tables.
Current ICMJE recommendations state that authors should avoid sponsor agreements that interfere with access to all study data or with their ability to analyze and interpret the data and prepare and publish manuscripts independently. ICMJE also recommends reporting whether authors had access to study data and describing the nature and extent of that access.
This makes investigator access to sponsor-funded data crucial when a dispute arises. Researchers cannot independently resolve an analytical disagreement if they are unable to inspect the evidence.
Correct genuine errors even when the correction helps the sponsor
Research independence does not mean defending your original conclusion at all costs.
If the sponsor demonstrates that your analysis contains an error, correct it. If the corrected result is more favorable to the sponsor, report that result. Your obligation is to the evidence, not to producing an outcome that proves your independence.
The same principle works in the other direction. If reanalysis confirms an unfavorable result, commercial discomfort is not a scientific reason to remove it.
Watch Out
Do not turn independence into stubbornness. The ethical standard is not “never agree with the sponsor.” It is “change the science when the evidence justifies the change, not because the sponsor has more bargaining power.”
Document important disagreements and changes
When a dispute leads to substantial analytical or interpretive changes, preserve a record of what changed and why. Versioned analysis code, dated analysis plans, meeting records, protocol amendments, and documented correspondence can help establish the scientific basis for decisions.
This becomes particularly important when an analysis is changed after investigators know the results. Readers may need to distinguish prespecified analyses from exploratory or post hoc work.
Documentation also protects both parties. It can show that a sponsor's recommendation corrected a legitimate problem rather than improperly changing an unfavorable result.
Independent review can break a scientific deadlock
Some disagreements are genuine rather than strategic. Two competent groups may prefer different models, interpret an ambiguous endpoint differently, or disagree about the practical significance of a finding.
An independent statistician, methodology committee, data-monitoring body, or other appropriately qualified reviewer may help determine whether one interpretation is clearly stronger or whether both should be presented.
Independent review is especially useful when the sponsor has a substantial proprietary interest and investigators want additional assurance that the resolution does not depend on either party's incentives.
The sponsor can be represented without receiving the final word
If the sponsor has a scientifically defensible alternative interpretation, researchers need not pretend it does not exist. Depending on the study and journal, the manuscript may explain alternative analyses, uncertainty, sensitivity analyses, or legitimate disagreement.
Sponsor employees who qualify for authorship may also participate in interpretation and manuscript revision like other authors. Their employment and relevant relationships should be disclosed.
What should not happen is automatic conversion of the sponsor's preferred interpretation into the manuscript's conclusion simply because the sponsor financed the project.
Publication independence matters when disagreement cannot be resolved
ICMJE states that authors should avoid agreements interfering with their ability to analyze, interpret, prepare, and publish manuscripts independently. It recommends reporting sponsor involvement and any restrictions regarding submission for publication.
If investigators and the sponsor ultimately disagree, a well-designed agreement should still allow scientifically defensible results to enter the research record.
A sponsor may have a defined right to review a manuscript before publication. That is different from possessing the power to prevent publication because it rejects the findings.
Escalate pressure through institutional channels
If sponsor disagreement becomes pressure to misrepresent results, conceal relevant findings, conduct unjustified analyses, or violate the research agreement, researchers should not handle the problem as a private negotiation indefinitely.
Depending on the situation, appropriate institutional contacts may include the principal investigator, department or research leadership, sponsored-research office, research-integrity office, conflict-of-interest committee, ethics or human-research office, legal counsel, data-monitoring body, or other authority responsible for the project.
The appropriate route varies by institution and research type. The key principle is that researchers should not allow a sponsor's leverage to isolate them from institutional oversight.
Safety and regulatory obligations may override ordinary publication disputes
If disagreement concerns participant safety, adverse events, regulatory reporting, or another mandatory disclosure, the issue may extend beyond manuscript interpretation.
Researchers should follow applicable reporting requirements and obtain institutional or regulatory guidance. A sponsor disagreement or confidentiality clause should not simply be assumed to override independent safety, ethical, legal, or regulatory obligations.
